A Rationally Engineered COL17A1-Mimetic Recombinant Peptide Regulating Basement Membrane Biointerfaces and Epidermal Redox Homeostasis
Xiance Chen , Liang Zhao , Yiyu Wang , Jingyi Yang , Weilin Pu , Yalin Yang , Leqi Li , Xinyuan Zhang , Xinrong Li , Shengwei Fu , Baihui Ji , Jiajia Li , Haiyan Chu , Wei Wu , Yi Lu , Wei Liu , Jiucun Wang , Zixin Hu , Yanyun Ma
Engineering ›› : 202607019
Type XVII collagen (COL17A1) deterioration compromises basement membrane (BM) integrity, disrupts dermal–epidermal adhesion, and contributes to skin barrier dysfunction under ultraviolet (UV) and oxidative stress. However, restoring COL17A1-associated extracellular functions remains a key challenge in skin-directed biomaterial design. Here, we report RCP17, a sequence-optimized COL17A1-mimetic recombinant peptide engineered by rationally integrating five functional ectodomain segments into a compact multidomain construct. This domain-integration strategy minimizes redundant collagen repeats while enabling the coordinated reinforcement of BM biointerfaces and the regulation of redox homeostasis. Molecular and biophysical characterization verified the identity, purity, and collagen-like structural features of RCP17. Molecular docking predicted structurally plausible interactions with epidermal growth factor receptor (EGFR) and integrin β4 (ITGB4), and surface plasmon resonance analysis further confirmed a measurable micromolar-affinity interaction between RCP17 and the EGFR ectodomain. In keratinocytes and ex vivo human skin explants, RCP17 upregulated COL17A1 expression and preserved BM architecture; furthermore, it was associated with EGFR–tissue inhibitor of metalloproteinases 1 (TIMP1)–matrix metalloproteinase (MMP)-related proteolytic regulation. In parallel, RCP17 attenuated oxidative stress, as supported by H2O2/N-acetylcysteine (NAC) rescue assays, nuclear factor erythroid 2-related factor 2 (NRF2)-associated antioxidant responses, and Ca2+–calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2)–AMP-activated protein kinase (AMPK)-related signaling changes. Transmission electron microscopy further revealed that RCP17 partially preserved hemidesmosome-associated ultrastructure and maintained lamina lucida–lamina densa continuity under UV stress. In a double-blind, placebo-controlled human efficacy study (n = 71; Institutional Review Board (IRB) No. E20240228A), topical RCP17 was well-tolerated and associated with favorable changes in noninvasive skin biophysical and imaging parameters, including hydration, erythema, wrinkle-related parameters, dermal density, gloss, and elasticity-related indices. Collectively, these findings establish RCP17 as a translationally relevant COL17A1-mimetic recombinant biomaterial that supports BM structural preservation and redox regulation in human skin models, demonstrating a functional domain-integration strategy for engineering multifunctional, collagen-inspired peptides for skin biointerface modulation and photodamage-associated skin protection.
Type XVII collagen / Recombinant biomaterial
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
/
| 〈 |
|
〉 |